UNSATURATED FREE FATTY-ACIDS INCREASE BENZODIAZEPINE RECEPTOR AGONISTBINDING DEPENDING ON THE SUBUNIT COMPOSITION OF THE GABA(A) RECEPTOR COMPLEX

Citation
Mr. Witt et al., UNSATURATED FREE FATTY-ACIDS INCREASE BENZODIAZEPINE RECEPTOR AGONISTBINDING DEPENDING ON THE SUBUNIT COMPOSITION OF THE GABA(A) RECEPTOR COMPLEX, Journal of neurochemistry, 67(5), 1996, pp. 2141-2145
Citations number
29
Categorie Soggetti
Biology,Neurosciences
Journal title
ISSN journal
00223042
Volume
67
Issue
5
Year of publication
1996
Pages
2141 - 2145
Database
ISI
SICI code
0022-3042(1996)67:5<2141:UFFIBR>2.0.ZU;2-W
Abstract
It has been shown previously that unsaturated free fatty acids (FFAs) strongly enhance the binding of agonist benzodiazepine receptor ligand s and GABAA receptor ligands in the CNS in vitro. To investigate the s electivity of this effect, recombinant human GABA(A)/benzodiazepine re ceptor complexes formed by different subunit compositions (alpha(x) be ta(y) gamma(2) X = 1, 2, 3, and 5; y = 1, 2, and 3) were expressed usi ng the baculovirus-transfected Sf9 insect cell system. At 10(-4) M, un saturated FFAs, particularly arachidonic (20:4) and docosahexaenoic (2 2:6) acids, strongly stimulated (>200% of control values) the binding of [H-3]flunitrazepam ([H-3] FNM) to the alpha(3) beta(2) gamma(2) rec eptor combination in whole cell preparations. No effect or small incre ases in levels of unsaturated FFAs on [H-3] FNM binding to alpha(1) be ta(x) gamma(2) and alpha(2) beta(x) gamma(2) receptor combinations wer e observed, and weak effects (130% of control values) were detected us ing the alpha(5) beta(x) gamma(2) receptor combination. The saturated FFAs, stearic and palmitic acids, were without effect on [H-3]FNM bind ing to any combination of receptor complexes. The hydroxylated unsatur ated FFAs, ricinoleic and ricinelaidic acids, were shown to decrease t he binding of [H-3] FNM Only if an alpha(1) beta(2) gamma(2) receptor combination was used. Given the heterogeneity of the GABA(A)/ benzodia zepine receptor subunit distribution in the CNS, the effects of FFAs o n the benzodiazepine receptor can be assumed to vary at both cellular and regional levels.